PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES

Transcription

1 KLEBSIELLA SPP. PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES INFECTIOUS AGENT NAME: Klebsiella spp. SYNONYM OR CROSS REFERENCE: Human pathogens include K. pneumoniae subspecies pneumoniae, ozaenae, and rhinoscleromatis; K. oxytoca; K. granulomatis; K. variicola; and K. singaporensis. CHARACTERISTICS: Klebsiella spp. are Gram-negative, nonmotile, usually encapsulated rod-shaped bacteria, belonging to the family Enterobacteriaceae. These bacteria produce lysine decarboxylase but not ornithine decarboxylase and are generally positive in the Voges-Proskauer test. Members of the Enterobacteriaceae family are generally facultative anaerobic, and range from 0.3 to 1.0 μm in width and 0.6 to 6.0 μm in length. Klebsiella spp. often occur in mucoid colonies. The genus consists of 77 capsular antigens (K antigens), leading to different serogroups. Klebsiella spp., gram-stained 1) Klebsiella spp. cells 2) HAZARD IDENTIFICATION PATHOGENICITY/TOXICITY: Klebsiella spp. have been identified as important common pathogens for nosocomial pneumonia (7 to 14% of all cases), septicaemia (4 to 15%), urinary tract infection (UTIs; 6 to 17%), wound infections (2 to 4%), intensive care unit (ICU) infections (4 to 17%), and neonatal septicaemias (3 to 20%). Klebsiella spp. can also cause bacteremias and hepatic infections, and have been isolated from a number of unusual infections. They are also important opportunistic pathogens, particularly among the immunocompromised. Pathogenicity factors of Klebsiella spp. include adhesins,

2 siderophores, capsular polysaccharides (CPLs), cell surface lipopolysaccharides (LPSs), and toxins, each of which plays a specific role in the pathogenesis of these species. Depending on the type of infection and the mode of infectivity, cells of Klebsiella spp. may adhere and attack upper respiratory tract epithelial cells, cells in gastrointestinal tract, endothelial cells, or uroepithelial cells, followed by colonization of mucosal membranes. Common underlying conditions include alcoholism, diabetes mellitus, chronic liver disease (cirrhosis), chronic renal failure, cancer, transplants, burns, and/or use of catheters. Respiratory disease: K. pneumoniae a leading cause of community-acquired and nosocomial pneumonia and lung abscesses. Infection of the upper lobe is more common. Symptoms include: fevers, chills, and leukocytosis with red currant jelly-like sputum. Rare complications include lung infection involving necrosis and sloughing of the entire lobe. K. ozaenae causes ozena, a primary atrophic rhinitis (AR) which involves chronic inflammation of the nose. K. rhinoscleromatis causes rhinoscleroma (RS), a chronic granulomatous infection which predominantly affects the cavity of the nose. Central nervous system (CNS) infections: K. pneumoniae and K. oxytoca cause community-acquired meningitis and brain abscesses. Clinical symptoms include: headaches, fever, altered conciousness, seizures, and septic shock. K. ozaenae associated with rare cases of cerebral abscess and meningitis. Urinary tract infections (UTIs): Klebsiella spp. are a frequent cause of UTIs. Significant bacteriuria has been ascribed to K. ozaenae. Hepatic disease: K. pneumoniae an important causative pathogen for pyogenic liver abscesses with symptoms including fever, right-upper-quadrant pain, nausea, vomiting, diarrhea or abdominal pain, and leukocytosis. Abscesses occur predominantly in the right lobe and are solitary. Other infections: K. granulomatis causes donovanosis or granuloma, a chronic ulcerative disease that primarily affects the genitalia. Symptoms include development of small papule or ulcer at the site of inoculation that later develop into large red ulcers (lesions) that extend along the moist folds of the genitalia.

3 EPIDEMIOLOGY: Klebsiella spp. occur worldwide, particularly in tropical and subtropical regions, and are ubiquitous, including forest environments, vegetation soil, water, and mucosal membranes of host species. Although they are common pathogens for communityacquired pneumonias and bacteremias, the majority of the infections are nosocomial (hospital-acquired; ~56% of all Klebsiella infections). Adult males are more susceptible to infection with Klebsiella spp. than adult females; however, Klebsiella spp. demonstrate higher colonization rates among neonates and may survive up to months as compared to a few days to weeks in adults. Risk of infection and carriage rates of Klebsiella spp. increases with increase in duration of stay within a hospital. Infection and carriage rates also increase with antimicrobial use. K. pneumoniae is most pathogenic to humans among all Klebsiella spp., followed by K. oxytoca, K. ozaenae, and K. rhinoscleromatis. K. granulomatis and K. variicola have also been identified as being pathogenic to humans. K. singaporensis is still very novel and its pathogenicity to humans has yet to be determined. Although, the number of infections is lower than some other pathogens, infections by Klebsiella spp. demonstrate substantial morbidity and mortality. K. pneumoniae occurs in the nasopharynx and intestinal tract of humans, as a saprophyte. It is one of the leading causes of community-acquired pneumonia. It is commonly isolated from infections of burns and human bites. Recently, it has become an increasing cause of chronic diarrhea in HIV infected adults in Africa. According to some reports, Klebsiella spp. are responsible for 16 to 43% of central nervous system (CNS) infections and brain abscesses. Environmental strains of K. pneumoniae have been shown to be equally virulent as clinical strains; however, whether this is true or not for other Klebsiella spp. has yet to be determined. HOST RANGE: Humans, mammals (including horses, bovines, rhesus and squirrel monkeys, guinea pigs, muskrats, lemurs, and bats), aquatic animals (including elephant seals, California sea lions, and harbor seals), reptiles (including snakes, crocodiles, and American alligators), birds, insects, and plants (banana, rice sugar cane and maize). INFECTIOUS DOSE: Unknown. According to one source, 10 8 Klebsiella organisms per gram of feces are required to produce damage. MODE OF TRANSMISSION: Klebsiella spp. can be transmitted through skin contact with environmentally contaminated surfaces and/or objects. Fecal transmission has also been suggested for some cases of bacteremia caused by Klebsiella spp. INCUBATION PERIOD: Not clearly understood. COMMUNICABILITY: Members of Klebsiella spp. can be transmitted from person-toperson; however, the communicability period is unknown. Approximately one-third of people carry Klebsiellae in their stools. Hospital personnel have been shown to frequently carry Klebsiellae on their hands.

4 DISSEMINATION RESERVOIR: Infected humans (with or without symptoms of disease) are the primary reservoir for Klebsiella spp. E.g., infected infants (usually asymptomatic) colonized with invasive strains of Klebsiella spp., and hospital patients (for nosocomial infections). Other sources include certain plants. ZOONOSIS: None. VECTORS: None. STABILITY AND VIABILITY DRUG SUSCEPTIBILITY: Klebsiella spp. are known to show resistance to penicillins, especially ampicillin and carbenicillin. Resistance of Klebsiella spp. to current antibiotics, however, appears to be increasing. SUSCEPTIBILITY TO DISINFECTANTS: Gram-negative bacteria are generally susceptible to a number of disinfectants, including phenolic compounds, hypochlorites (1% sodium hypochlorite), alcohols (70% ethanol), formaldehyde (18.5 g/l; 5% formalin in water), glutaraldehyde, and iodines (0.075 g/l). PHYSICAL INACTIVATION: Reduction in the growth and metabolic activity of K. pneumoniae at temperatures >35 C has been reported. Significant growth reduction has been demonstrated at 60 C; however, the bacteria still show some metabolic activity (i.e. not completely inactivated). Bacteria are also sensitive to moist heat and dry heat. SURVIVAL OUTSIDE HOST: Klebsiella spp. grow rapidly on surfaces of potatoes and lettuce with counts exceeding 10 3 organisms per g of surface. They also survive well within wood and sawdust. They do not grow well on human skin but can survive for extended periods of time in surface water, sewage, soil, and on plants. FIRST AID / MEDICAL SURVEILLANCE: Monitor for symptoms. Other tests include isolating strains of the bacteria or typing different isolates. This is often necessary for investigation of endemic and epidemic nosocomial infections and also for epidemiological investigations from the environment. Klebsiellae can be isolated by growth in media; they grow well on blood and non-differential media. Biotyping and serotyping are two common forms of typing methods used for typing Klebsiella spp. Serotyping is the most widely used technique for typing these bacteria. Biotyping is not preferred due to the large number of reactions and the amount of time required to complete these tests. Molecular typing methods are also being developed, although they are not commonly used. FIRST AID/TREATMENT: Administer appropriate antibiotic therapy where necessary.

5 IMMUNIZATION: None. PROPHYLAXIS: None. LABORATORY HAZARD LABORATORY-ACQUIRED INFECTIONS: 1 case of laboratory-acquired infection with K. pneumoniae up to 1976 has been reported. SOURCES/SPECIMENS: Sources for clinical samples of Klebsiella spp. primarily include samples from respiratory tract (RT; nasopharyngeal samples) and urinary tract (UT). Specific sources identified include: K. pneumoniae all sites within the human body, RT and UT most common K. ozaenae nasal discharge most common, RT, UT, and blood K. rhinoscleromatis nasal discharge K. oxycota all sites within the human body K. granulomatis genital tract K. variicola blood, banana plants, rice, sugar cane, and maize K. singaporensis soil (from roots of sugar cane) PRIMARY HAZARDS: Direct contact of mucosal membranes with contaminated surfaces and/or object, and inhalation of infectious airborne secretions, accidental parenteral inoculation and/or ingestion. SPECIAL HAZARDS: None. EXPOSURE CONTROLS / PERSONAL PROTECTION RISK GROUP CLASSIFICATION: Risk Group 2. The risk group associated with Klebsiella spp. reflects the genus as a whole, but does not necessarily reflect the risk group classification of every species within the genus. CONTAINMENT REQUIREMENTS: Containment Level 2 facilities, equipment, and operational practices for work involving infectious or potentially infectious materials, animals, or cultures. The containment and operational requirements may vary with the species, subspecies, and/or strains. PROTECTIVE CLOTHING: Lab coat. Gloves when direct skin contact with infected materials or animals is unavoidable. Eye protection must be used where there is a known or potential risk of exposure to splashes. OTHER PRECAUTIONS: All procedures that may produce aerosols, or involve high concentrations or large volumes should be conducted in a biological safety cabinet (BSC).

6 The use of needles, syringes, and other sharp objects should be strictly limited. Additional precautions should be considered with work involving animals or large scale activities. HANDLING AND STORAGE SPILLS: Allow aerosols to settle and, wearing protective clothing, gently cover spill with paper towels and apply appropriate disinfectant, starting at the perimeter and working towards the centre. Allow sufficient contact time before clean up. DISPOSAL: Decontaminate all wastes that contain or have come in contact with the infectious organism before disposing by autoclave, chemical disinfection, gamma irradiation, or incineration. STORAGE: The infectious agent should be stored in leak-proof containers that are appropriately labeled. REFERENCE Pathogen Safety Data Sheet (PSDS) for Klebsiella spp. has been modified from the ones produced by the Public Health Agency of Canada as educational and informational resources for laboratory personnel working with infectious substances. 1) Picture from 2) Picture from